[Unique medullary neurosarcoidosis].

Mickaël Alexandre Obadia(Fondation Ophtalmologique Adolphe de Rothschild), Catherine Lubetzki(Centre National de la Recherche Scientifique), Karima Mokhtari(Inserm), S. Clémenceau, A. Azoulay, Didier Dormont(Sorbonne Université), Sophie Crozier

PubMed

January 1, 1999

Cited by 2

Related Papers

Defining the clinical course of multiple sclerosis

|Neurology|2014|3.1k

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

|Multiple Sclerosis Journal|2018|706

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

|The Lancet|2009|587

Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines

|Brain|2019|554

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

|The Lancet|2016|449